- Home
- ECO vs OPK Comparison
ECO vs OPK Comparison
Compare ECO & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECO
- OPK
- Stock Information
- Founded
- ECO 2018
- OPK 2007
- Country
- ECO Greece
- OPK United States
- Employees
- ECO N/A
- OPK N/A
- Industry
- ECO
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ECO
- OPK Health Care
- Exchange
- ECO Nasdaq
- OPK Nasdaq
- Market Cap
- ECO 740.1M
- OPK 1.1B
- IPO Year
- ECO N/A
- OPK 1995
- Fundamental
- Price
- ECO $22.15
- OPK $1.52
- Analyst Decision
- ECO Strong Buy
- OPK Strong Buy
- Analyst Count
- ECO 1
- OPK 3
- Target Price
- ECO $44.00
- OPK $2.75
- AVG Volume (30 Days)
- ECO 218.0K
- OPK 3.8M
- Earning Date
- ECO 02-19-2025
- OPK 02-25-2025
- Dividend Yield
- ECO 15.57%
- OPK N/A
- EPS Growth
- ECO N/A
- OPK N/A
- EPS
- ECO 3.63
- OPK N/A
- Revenue
- ECO $399,710,831.00
- OPK $711,408,000.00
- Revenue This Year
- ECO N/A
- OPK N/A
- Revenue Next Year
- ECO $15.33
- OPK $0.00
- P/E Ratio
- ECO $5.59
- OPK N/A
- Revenue Growth
- ECO N/A
- OPK N/A
- 52 Week Low
- ECO $18.79
- OPK $0.85
- 52 Week High
- ECO $36.69
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- ECO 54.14
- OPK 45.08
- Support Level
- ECO $20.10
- OPK $1.43
- Resistance Level
- ECO $21.73
- OPK $1.54
- Average True Range (ATR)
- ECO 0.81
- OPK 0.06
- MACD
- ECO 0.47
- OPK -0.01
- Stochastic Oscillator
- ECO 94.13
- OPK 24.24
About ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers, and eight VLCC tankers.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.